Bioelectronics Corp Financials
| BIEL Stock | USD 0.0003 0.0001 50.00% |
Bioelectronics |
Understanding current and past Bioelectronics Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bioelectronics Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Bioelectronics Corp's assets may result in an increase in income on the income statement.
Bioelectronics Corp Stock Summary
Bioelectronics Corp competes with Cellink AB, Bone Biologics, BICO Group, Brain Scientific, and Tenon Medical. BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US09062H1086 |
| Business Address | 45 Metropolitan Court, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.bielcorp.com |
| Phone | 301 874 4890 |
| Currency | USD - US Dollar |
Bioelectronics Corp Key Financial Ratios
There are many critical financial ratios that Bioelectronics Corp's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bioelectronics Corp reports annually and quarterly.Bioelectronics Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bioelectronics Corp's current stock value. Our valuation model uses many indicators to compare Bioelectronics Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioelectronics Corp competition to find correlations between indicators driving Bioelectronics Corp's intrinsic value. More Info.Bioelectronics Corp is rated fifth in return on asset category among its peers. It is rated third in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioelectronics Corp's earnings, one of the primary drivers of an investment's value.Bioelectronics Corp Systematic Risk
Bioelectronics Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bioelectronics Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Bioelectronics Corp correlated with the market. If Beta is less than 0 Bioelectronics Corp generally moves in the opposite direction as compared to the market. If Bioelectronics Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bioelectronics Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bioelectronics Corp is generally in the same direction as the market. If Beta > 1 Bioelectronics Corp moves generally in the same direction as, but more than the movement of the benchmark.
Bioelectronics Corp January 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bioelectronics Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bioelectronics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bioelectronics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Bioelectronics Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bioelectronics Corp's daily price indicators and compare them against related drivers.
| Downside Deviation | 34.11 | |||
| Information Ratio | 0.1442 | |||
| Maximum Drawdown | 83.33 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 50.0 |
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.